Design and synthesis of resveratrol–salicylate hybrid derivatives as CYP1A1 inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of resveratrol–salicylate hybrid derivatives as CYP1A1 inhibitors

Published:2014-11-19 Issue:6 Volume:30 Page:884-895
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Aldawsari Fahad S.¹,Elshenawy Osama H.¹,El Gendy Mohamed A. M.²³,Aguayo-Ortiz Rodrigo⁴,Baksh Shairaz⁵⁶,El-Kadi Ayman O. S.¹,Velázquez-Martínez Carlos A.¹

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada,

2. Experimental Oncology Unit, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada,

3. Department of Pharmacognosy, Pharmaceutical Sciences Division, Natural Research Centre, Dokki, Giza, Egypt,

4. Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, México,

5. Department of Pediatrics, Oncology and Biochemistry, University of Alberta, Edmonton, Alberta, Canada, and

6. Alberta Inflammatory Bowel Disease Consortium, Alberta, Canada

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/14756366.2014.979347

Reference48 articles.

1. Activation of procarcinogens by human cytochrome P450 enzymes

2. Practical Application of Cytochrome P450

3. Expression of cytochrome P450 in tumor tissues and its association with cancer development

4. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

5. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises;European Journal of Pharmacology;2024-10

2. Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib);Archives of Biochemistry and Biophysics;2024-09

3. Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol;Drug Metabolism Reviews;2023-02-23

4. Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs;Molecules;2020-08-24

5. Resveratrol – A comprehensive review of recent advances in anticancer drug design and development;European Journal of Medicinal Chemistry;2020-08